1 / 4

Global Wearable Injectors Market Expected to Reach US$ 13.0 Bn by 2024

Global Wearable Injectors market report provides analysis for the period 2012–2024. The market study reveals that the Global Wearable Injectors market is projected to rise over a CAGR of 24.53% during 2018-2024 in terms of value. This growth is driven by rising usage of advance drug delivery devices at home. Rise in prevalence of chronic diseases among old age population is surging the demand for wearable injector’s products over the projected time frame.

Download Presentation

Global Wearable Injectors Market Expected to Reach US$ 13.0 Bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Wearable Injectors Market: Overview According to a market report published by BlueWeave Consulting, the global wearable injectors market is expected to reach a value of US$ 13.0 Bn by 2024, owing to growing burden of geriatric population, increasing prevalence of chronic diseases, high demand for advanced drug delivery and increasing compliance for controlled drug delivery. The emerging economies offer ample growth opportunities for the global of wearable injectors market. However, alternative drug delivery methods hinder the growth of the global market. The market is projected to expand at a CAGR of 23.0% during the forecast period from 2018 to 2024 by value. Accelerating pervasiveness of chronic diseases is driving the market growth. Request for Sample Copy of Study Report on Wearable Injectors Market: https://bit.ly/2FnyA3x The demand for wearable injectors is increasing due to increasing prevalence of chronic and lifestyle associated diseases. The prevalence of chronic diseases, such as heart disease, cancer, stroke, and diabetes, is increasing due to the alteration in lifestyle and lack of access to preventive care. As reported by WHO in 2014, there were 422 million adults suffering from diabetes. Eastern Mediterranean region had the highest prevalence of diabetes (13.7%) in 2014, followed by South-East Asia (8.6%). According to Centre for Disease Control and Prevention (CDC), approximately 117 million people in 2012 in the U.S. had one or more chronic health conditions. Wearable Injectors Market: Scope of the Report The wearable injectors market can be segmented on the basis type, technology, application, end user and geography. Based on type, the global wearable injectors market is classified into body-worn patch injector, off-body worn belt injector, and bolus injector. Bolus injector market is expected to witness the fastest growth and is expected to grow at a CAGR of 42.36% during the forecast period. In end- user segment, the sale of wearable injectors in homecare segment is dominating. North America is expected to lead the global wearable injectors market during the forecast period North America led the global wearable injectors market; owing to rise in ageing population in the region the market has witness gain in terms of revenue in 2017. The North American wearable injectors market is expected to grow at a CAGR of 24.48% during the period 2018– 2024. Global Wearable Injectors Market: Competitive Dynamics The research study includes profiles of leading companies operating in the global Wearable Injectors market. Some of the key players profiled in the report include Johnson & Johnson, Medtronic plc, F. Hoffmann-La Roche Ltd, Unilife Corporation, etc. Get Complete Table of Content Having Unique Analysis on Several Factors: https://bit.ly/2HpvvCx The global Wearable Injectors market is segmented as below

  2. Global Wearable Injectors Market, by Type  Body-worn patch injector  Off-body worn belt injector  Bolus injector Global Wearable Injectors Market, by Technology  Electronical injector  Mechanical injector  Others Global Wearable Injectors Market, by Application  Cancer  Infectious disease  Autoimmune disorder  Cardiovascular disease  Blood disorder  Others Global Wearable Injectors Market, by End-user  Home care  Hospital  Lab & diagnostics  Others Global Wearable Injectors Market, by Geography  North America  The U.S.  Canada  Rest of North America

  3. Europe  Germany  Italy  UK  France  Rest Of Europe  Asia Pacific (APAC)  India  China  Japan  Rest of APAC  Middle East & Africa (MEA)  Latin America  Brazil  Rest of Latin America Full Study Report on Global Wearable Injectors Market: https://bit.ly/2Dr04UA About Us BlueWeave Consulting is a one-stop solution for market intelligences regarding various products and services online & offline. We offer worldwide market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BlueWeave has built its reputation from the scratches by delivering quality performance and nourishing the long-lasting relationships with its clients for years. We are one of the leading digital market intelligence generation company delivering unique solutions for blooming your business and making the morning, more rising & shining. Contact Us: Email: info@blueweaveconsulting.com Website: www.blueweaveconsulting.com Phone: +1 8666586826

More Related